AU1789900A - Compounds for control of eating, growth and body weight - Google Patents

Compounds for control of eating, growth and body weight

Info

Publication number
AU1789900A
AU1789900A AU17899/00A AU1789900A AU1789900A AU 1789900 A AU1789900 A AU 1789900A AU 17899/00 A AU17899/00 A AU 17899/00A AU 1789900 A AU1789900 A AU 1789900A AU 1789900 A AU1789900 A AU 1789900A
Authority
AU
Australia
Prior art keywords
eating
growth
compounds
control
body weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17899/00A
Inventor
Ruta Muceniece
Ilze Mutule
Felikss Mutulis
Helgi Schioth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Melacure Therapeutics AB
Original Assignee
Melacure Therapeutics AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melacure Therapeutics AB filed Critical Melacure Therapeutics AB
Publication of AU1789900A publication Critical patent/AU1789900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU17899/00A 1998-12-14 1999-12-14 Compounds for control of eating, growth and body weight Abandoned AU1789900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9827500.1A GB9827500D0 (en) 1998-12-14 1998-12-14 Compounds for control of eating, growth and body weight
GB9827500 1998-12-14
PCT/GB1999/004254 WO2000035952A2 (en) 1998-12-14 1999-12-14 Compounds for control of eating, growth and body weight

Publications (1)

Publication Number Publication Date
AU1789900A true AU1789900A (en) 2000-07-03

Family

ID=10844193

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17899/00A Abandoned AU1789900A (en) 1998-12-14 1999-12-14 Compounds for control of eating, growth and body weight

Country Status (3)

Country Link
AU (1) AU1789900A (en)
GB (1) GB9827500D0 (en)
WO (1) WO2000035952A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716810B1 (en) 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
HUP0202203A3 (en) 1999-03-29 2003-09-29 Procter & Gamble Melanocortin receptor ligands, pharmaceutical compositions comprising thereof and method for their preparation
WO2003006620A2 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
WO2001052880A1 (en) 2000-01-18 2001-07-26 Merck & Co., Inc. Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
GB0019357D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
GB0019359D0 (en) * 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel guanidines
US7342089B2 (en) * 2001-07-11 2008-03-11 Palatin Technologies, Inc. Cyclic peptides for treatment for cachexia
EP1425029A4 (en) 2001-08-10 2006-06-07 Palatin Technologies Inc Peptidomimetics of biologically active metallopeptides
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
WO2005000339A2 (en) * 2003-06-19 2005-01-06 Eli Lilly And Company Melanocortin receptor 4(mc4) agonists and their uses
CN1909930B (en) 2004-01-21 2015-12-16 诺和诺德医疗保健公司 The joint of transglutaminase mediated peptide
DE102007020152A1 (en) * 2007-04-26 2008-10-30 Charité - Universitätsmedizin Berlin Agent for anti-infective treatment of a patient
AU2009257631B2 (en) 2008-06-09 2014-07-24 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
UY32690A (en) 2009-06-08 2011-01-31 Astrazeneca Ab SPECIFIC PEPTIDES FOR MELANOCORTIN RECEPTORS
KR101726893B1 (en) 2009-06-08 2017-04-13 팔라틴 테크놀로지스 인코포레이티드 Melanocortin receptor-specific peptides
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
MX2012005859A (en) 2009-11-23 2012-12-17 Palatin Technologies Inc Melanocortin-1 receptor-specific linear peptides.
WO2011063366A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
AU2014227712B2 (en) * 2013-03-15 2018-08-02 Rhythm Pharmaceuticals, Inc. Peptide compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
SE9700620D0 (en) * 1997-02-21 1997-02-21 Wapharm Ab Cyclic peptides with selectivity for MSH receptor subtypes

Also Published As

Publication number Publication date
WO2000035952A3 (en) 2000-10-19
GB9827500D0 (en) 1999-02-10
WO2000035952A2 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
AU1789900A (en) Compounds for control of eating, growth and body weight
AU1746600A (en) Reduction, elimination, or stimulation of hair growth
AU1416695A (en) 1-H-3-aryl-pyrrolidine-2,4-dione derivatives as pesticides
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU1160297A (en) Nicotine metabolites, nicotine dependence and human body weight
AU6514196A (en) Heterocyclic compounds, their preparation and use
AU2583200A (en) Heart valve prosthesis
AU6683496A (en) Use of griseofulvin for inhibiting the growth of cancers
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU3117600A (en) Composition and method for regulation of body weight and associated conditions
AUPQ137699A0 (en) Control of acidosis
AU6372496A (en) Absorbent material, absorbent body made of the material, and method for the preparation of the material
AU7755398A (en) Method for reducing body weight
AU5671099A (en) Compounds having growth hormone releasing activity
AU8586198A (en) Growth differentiation factor, lefty-1
AU8580098A (en) Growth differentiation factor, lefty-2
AUPQ044499A0 (en) Control of wool growth
AU3910900A (en) Antisense modulation of sra expression
AU5915599A (en) Biocompatible emulsifier
AU5781296A (en) Triazolone derivatives, use thereof, and intermediates for t he preparation thereof
AU2223599A (en) Human growth factor homologs
AU6926298A (en) Photoperiodic control of growth
AU2410899A (en) Heart valve prosthesis
AU9647798A (en) Plant planting body
AU5419400A (en) Thienyl-pyrazoles and their use for controlling pests

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase